The objective of the present project was the determination of the dose
received by patients during cardiac procedures, such as coronary angi
ography, percutaneous transluminal coronary angioplasty (PTCA) and ste
nt implantation. Thermoluminescent dosemeters (TLDs), suitably calibra
ted, were used for the measurement of the dose received at four anatom
ical locations on the patient's skin. A dose-area product (DAP) meter
mas also used. The contribution of cinefluorography to the total DAP w
as higher than that of fluoroscopy. A DAP to effective dose conversion
factor equal to 0.183 mSv Gy(-1) cm(-2) was estimated with the help o
f a Rando phantom. Thus, the effective dose received by the patients c
ould be assessed. Mean values of effective dose equal to 5.6 mSv, 6.9
mSv, 9.3 mSv, 9.0 mSv and 13.0 mSv were estimated for coronary angiogr
aphy, PTCA, coronary angiography and nd hoc PTCA, PTCA followed by ste
nt implantation and coronary angiography and ad hoc PTCA followed by s
tent implantation, respectively.